Abbott reports q1 gaap eps from continuing operations of $0.30

Abbott reports first-quarter 2020 results.q1 adjusted earnings per share $0.65 from continuing operations.q1 gaap earnings per share $0.30 from continuing operations.q1 earnings per share estimate $0.58 -- refinitiv ibes data.due to uncertainties regarding duration, impact of coronavirus pandemic, co is suspending previously announced 2020 annual guidance.first-quarter worldwide sales of $7.7 billion increased 2.5 percent on a reported basis and 4.3 percent on an organic basis.q1 revenue view $7.34 billion -- refinitiv ibes data.quarterly total nutrition sales $1.90 billion versus $1.79 billion reported last year.suspending its previously announced annual guidance for 2020.quarterly total diagnostics sales $1.83 billion versus $1.84 billion reported last year.on an organic basis, worldwide sales increased 4.3 percent in quarter.qtrly total pediatric nutrition sales $1.09 billion.core laboratory diagnostics sales growth was negatively impacted by lower routine testing volumes due to the coronavirus in quarter.abbott - qtrly worldwide nutrition sales growth positively impacted by increased demand in late march in advance of shelter-in-place restrictions for coronavirus.abbott - qtrly sales growth in cardiovascular, neuromodulation medical devices businesses negatively impacted by reduced procedure volumes due to covid-19.
ABT Ratings Summary
ABT Quant Ranking